ValuEngine cut shares of UnitedHealth Group Incorporated (NYSE:UNH) from a buy rating to a hold rating in a research report report published on Thursday morning.

Other equities research analysts have also issued research reports about the stock. Cantor Fitzgerald reissued a buy rating and set a $205.00 target price on shares of UnitedHealth Group in a research note on Friday, July 7th. Stifel Nicolaus reissued a buy rating and set a $185.00 target price on shares of UnitedHealth Group in a research note on Wednesday, June 28th. BidaskClub raised shares of UnitedHealth Group from a hold rating to a buy rating in a research note on Friday, June 9th. Mizuho set a $235.00 target price on shares of UnitedHealth Group and gave the company a buy rating in a research note on Tuesday, July 18th. Finally, Cowen and Company reissued a buy rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Three equities research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. UnitedHealth Group has an average rating of Buy and an average target price of $203.59.

UnitedHealth Group (NYSE:UNH) opened at 198.06 on Thursday. The company has a 50 day moving average price of $196.36 and a 200 day moving average price of $183.56. UnitedHealth Group has a 12 month low of $133.03 and a 12 month high of $200.76. The stock has a market capitalization of $191.50 billion, a price-to-earnings ratio of 23.79 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. The company had revenue of $50.05 billion during the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter last year, the business posted $1.96 EPS. Equities research analysts predict that UnitedHealth Group will post $9.87 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/08/unitedhealth-group-incorporated-unh-cut-to-hold-at-valuengine.html.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. UnitedHealth Group’s payout ratio is 35.13%.

In other news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the transaction, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 76,174 shares of company stock worth $14,981,909. Insiders own 0.89% of the company’s stock.

Several large investors have recently bought and sold shares of the company. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 1.2% during the 2nd quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the period. Vanguard Group Inc. increased its holdings in shares of UnitedHealth Group by 2.5% during the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC increased its holdings in shares of UnitedHealth Group by 2.1% during the 2nd quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. State Street Corp increased its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after purchasing an additional 1,122,534 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in shares of UnitedHealth Group by 2.3% during the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the period. Institutional investors own 86.19% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.